Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

380 ARTÍCULOS , VIENDO DEL 271 AL 285

Association between Neuropsychiatric Improvement and Neurocognitive Change in Alzheimer's Disease: Analysis of the CATIE-AD Study

Nagata T, Shinagawa S, Nakajima S, Mimura M, Shigeta M.

J Alzheimers Dis. 2018;66(1):139-148. doi: 10.3233/JAD-180304.

Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial

Lawlor B, Segurado R, Kennelly S, Olde Rikkert MGM, Howard R, Pasquier F, Börjesson-Hanson A, Tsolaki M, Lucca U, Molloy DW, Coen R, Riepe MW, Kálmán J, Kenny RA, Cregg F, O'Dwyer S, Walsh C, Adams J, Banzi R, Breuilh L, Daly L, Hendrix S, Aisen P, Gaynor S, Sheikhi A, Taekema DG, Verhey FR, Nemni R, Nobili F, Franceschi M, Frisoni G, Zanetti O, Konsta A, Anastasios O, Nenopoulou S, Tsolaki-Tagaraki F, Pakaski M, Dereeper O, de la Sayette V, Sénéchal O, Lavenu I, Devendeville A, Calais G, Crawford F, Mullan M; NILVAD Study Group.

PLoS Med. 2018 Sep 24;15(9):e1002660. doi: 10.1371/journal.pmed.1002660. eCollection 2018 Sep.

Resveratrol and Alzheimer's disease. From molecular pathophysiology to clinical trials

Drygalski K, Fereniec E, Koryciński K, Chomentowski A, Kiełczewska A, Odrzygóźdź C, Modzelewska B.

Exp Gerontol. 2018 Nov;113:36-47. doi: 10.1016/j.exger.2018.09.019. Epub 2018 Sep 25.

Alzheimer's disease (AD) therapeutics - 2: Beyond amyloid - Re-defining AD and its causality to discover effective therapeutics

Mullane K, Williams M.

Biochem Pharmacol. 2018 Dec;158:376-401. doi: 10.1016/j.bcp.2018.09.027. Epub 2018 Sep 29.

Alzheimer's disease (AD) therapeutics - 1: Repeated clinical failures continue to question the amyloid hypothesis of AD and the current understanding of AD causality

Mullane K, Williams M.

Biochem Pharmacol. 2018 Dec;158:359-375. doi: 10.1016/j.bcp.2018.09.026. Epub 2018 Sep 29.

Neuroprotective Effects of Amylin Analogues on Alzheimer's Disease Pathogenesis and Cognition

Grizzanti J, Corrigan R, Casadesus G.

J Alzheimers Dis. 2018;66(1):11-23. doi: 10.3233/JAD-180433.

Incidence and Prevalence of Antiepileptic Medication Use in Community-Dwelling Persons with and without Alzheimer's Disease

Sarycheva T, Taipale H, Lavikainen P, Tiihonen J, Tanskanen A, Hartikainen S, Tolppanen AM.

J Alzheimers Dis. 2018;66(1):387-395. doi: 10.3233/JAD-180594.

France Will No More Reimburse Available Symptomatic Drugs Against Alzheimer's Disease

Krolak-Salmon P, Dubois B, Sellal F, Delabrousse-Mayoux JP, Vandel P, Amieva H, Jeandel C, Andrieu S, Perret-Liaudet A.

J Alzheimers Dis. 2018;66(2):425-427. doi: 10.3233/JAD-180843.

Mitochondrial therapeutic interventions in Alzheimer's disease

Van Giau V, An SSA, Hulme JP.

J Neurol Sci. 2018 Dec 15;395:62-70. doi: 10.1016/j.jns.2018.09.033. Epub 2018 Sep 28.

Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer's disease: results of a randomized, double-blind, placebo-controlled phase 2a study

Scheltens P, Hallikainen M, Grimmer T, Duning T, Gouw AA, Teunissen CE, Wink AM, Maruff P, Harrison J, van Baal CM, Bruins S, Lues I, Prins ND.

Alzheimers Res Ther. 2018 Oct 12;10(1):107. doi: 10.1186/s13195-018-0431-6.

The Mechanisms of Dietary Phytoestrogen as a Potential Treatment and Prevention Agent against Alzheimer's Disease

Hussain A, Tabrez ES, Muhammad A, Peela JR.

Crit Rev Eukaryot Gene Expr. 2018;28(4):321-327. doi: 10.1615/CritRevEukaryotGeneExpr.2018025847.

Effect of Exercise on Drug-Related Falls Among Persons with Alzheimer's Disease: A Secondary Analysis of the FINALEX Study

Perttila NM, Öhman H, Strandberg TE, Kautiainen H, Raivio M, Laakkonen ML, Savikko N, Tilvis RS, Pitkälä KH.

Drugs Aging. 2018 Nov;35(11):1017-1023. doi: 10.1007/s40266-018-0594-7.

Alzheimer's Disease, time to turn the tide

Sensi SL.

Aging (Albany NY). 2018 Oct 13;10(10):2537-2538. doi: 10.18632/aging.101581.

Copper-64: a real theranostic agent

Gutfilen B, Souza SA, Valentini G.

Drug Des Devel Ther. 2018 Oct 2;12:3235-3245. doi: 10.2147/DDDT.S170879. eCollection 2018.

Clinical efficacy and safety of donepezil in the treatment of Alzheimer's disease in Chinese patients

Zhang N, Gordon ML.

Clin Interv Aging. 2018 Oct 11;13:1963-1970. doi: 10.2147/CIA.S159920. eCollection 2018.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias